Rare diseases
Investigational molecules
Locations
Ul. Powstania Styczniowego 9b, 81-519 Gdynia, Poland
Uniwersyteckie Centrum Medycyny Morskiej I Tropikalnej in Gdynia, Poland specialises in clinical trials of conditions such as Cardiac failure acute, Cardiac failure chronic, Heart failure with preserved ejection fraction, Obesity, and other specialisations. This site conducts important research.
The medical center is at the forefront of cardiovascular medicine, focusing on innovative treatments for acute heart failure. Through rigorous clinical trials, the center explores the efficacy of novel therapeutic agents like dapagliflozin in improving patient outcomes.
By initiating treatment during hospitalization, the center aims to reduce the incidence of cardiovascular death and worsening heart failure, setting new standards in patient care.
Specializing in the intersection of mental health and heart disease, the center investigates the impact of sertraline on anxiety-depressive symptoms in patients with heart failure and preserved ejection fraction. This research is pivotal in understanding the role of mental health in cardiovascular conditions.
The center's work in this field aims to improve quality of life and reduce hospitalizations, highlighting the importance of comprehensive care in heart failure management.
Focusing on the use of SGLT-2 inhibitors like empagliflozin and dapagliflozin, the center conducts research to enhance outcomes for patients with acute/decompensated heart failure. This includes patients with varying ejection fractions and diabetes status.
By comparing the effects of these inhibitors, the center contributes to a deeper understanding of heart failure treatment, aiming to tailor therapies to individual patient needs.
Clinical trials currently enrolling participants at this site.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
PolandStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
PolandStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
PolandStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
PolandStudy on Empagliflozin and Dapagliflozin for Patients Hospitalized with Acute Heart Failure
PolandStudy on the Effects of Sertraline on Anxiety and Depression in Heart Failure Patients with Preserved Ejection Fraction
PolandStudy of dapagliflozin effects in patients hospitalized with acute heart failure
PolandStudy on the Effects of Oxygen Therapy with Vedolizumab, Ustekinumab, or Infliximab for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effects of Trimetazidine on Heart Failure with Preserved Ejection Fraction in Patients
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
